Longitudinal Study of Genetic Causes of Intrahepatic Cholestasis (LOGIC) | MicrobiomeTrials← Back to trialsNCT00571272
Longitudinal Study of Genetic Causes of Intrahepatic Cholestasis (LOGIC)
SUSPENDEDOBSERVATIONAL
Trial Details
Start: 2007-11-30Est. Completion: 2029-05-31
Enrollment target: 1,675 participants Locations- Children's Hospital of Los Angeles, Los Angeles, California, United States
- University of California at San Francisco (UCSF), San Francisco, California, United States
- Children's Hospital Colorado, Aurora, Colorado, United States
- Children's Healthcare of Atlanta - Emory University, Atlanta, Georgia, United States
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States
- Riley Hospital for Children, Indianapolis, Indiana, United States
- Johns Hopkins University Hospital, Baltimore, Maryland, United States
- St. Louis University - Cardinal Glennon Children's Medical Center, St Louis, Missouri, United States
- Washington University School of Medicine/St. Louis Children's Hospital, St Louis, Missouri, United States
- Mount Sinai School of Medicine, New York, New York, United States
- Cincinnati's Children's Memorial Hospital, Cincinnati, Ohio, United States
- Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
- UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, United States
- Baylor School of Medicine, Houston, Texas, United States
Other microbiome trials you might be interested in
Advanced CancerPancreatic Cancer
This is a prospective, single-arm, pilot feasibility clinical trial designed to evaluate the feasibility and safety of a…
Toronto, CanadaEst. completion Jun 1, 2027
Alcohol Use Disorder
Patients with hepatic steatosis due to alcohol will be offered liver biopsies when they enter a detoxification program. …
Bethesda, United StatesEst. completion Nov 30, 2027
University of Utah, Salt Lake City, Utah, United StatesSeattle Children's Hospital, Seattle, Washington, United StatesThe Hospital for Sick Children, Toronto, Ontario, CanadaHepatocellular Carcinoma (HCC)
Cirrhosis
Risk Prediction for Liver Cancer
Epigenomics
This study aims to evaluate the role of the circulating epigenetic biomarker mSEPT9 in predicting the risk of hepatocell…
Vandœuvre-lès-Nancy, FranceEst. completion Jun 3, 2033